Christiana Stamoulis serves as the Executive Vice President and Chief Financial Officer at INCYTE CORP, a leading biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines. With a robust background in finance and strategic management, Stamoulis has been instrumental in guiding INCYTE's financial strategy and growth. She joined INCYTE in 2011 and has since played a pivotal role in steering the company through various stages of expansion and development. Prior to her tenure at INCYTE, Stamoulis held significant positions at major corporations, including roles at AstraZeneca and Bristol-Myers Squibb. Her experience in the pharmaceutical industry has equipped her with deep insights into the financial intricacies of drug development and commercialization. At INCYTE, she has been recognized for her strategic foresight, particularly in navigating the company through complex financial landscapes and ensuring sustainable growth. Under her leadership, INCYTE has achieved notable milestones, including successful product launches and robust financial performance. As CFO, Christiana Stamoulis oversees all aspects of INCYTE's financial operations, including financial planning and analysis, accounting, and investor relations. Her strategic vision and leadership have been crucial in maintaining INCYTE's position at the forefront of the biopharmaceutical industry. Stamoulis's dedication to fostering innovation and excellence in financial management continues to drive INCYTE's success, making her an invaluable asset to the company.